Recent Updates
Recently added Catalysts
IDXX Positive Sentiment

IDEXX Laboratories to Release 2026 Third Quarter Financial Results

Thursday, October 1, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: IDEXX Laboratories, Inc. has announced the release date for its 2026 third quarter financial results, set for November 2, 2026. The company will host an analyst conference call at 8:30 a.m. ET on the same day. Investors and analysts can access a live webcast and a transcript of the prepared remarks.

Market Sentiment Analysis

POSITIVE FACTORS

  • IDEXX Laboratories is a leader in pet healthcare innovation.
  • The scheduled release indicates strong financial planning.
  • The conference call allows for direct engagement with analysts.

Full Press Release Details

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 third quarter financial results for Monday, November 2, 2026, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q3 2026 Earnings Snapshot through a link on the IDEXX websi

Frequently Asked Questions

When will IDEXX release its Q3 2026 financial results?

IDEXX will release its Q3 2026 financial results on November 2, 2026.

What time is the IDEXX analyst conference call?

The analyst conference call will begin at 8:30 a.m. ET on November 2, 2026.

How can I access the IDEXX conference call?

You can access the conference call via a live webcast link on the IDEXX website.

ShareAdd on Google
Tags: IDXX IDEXX Laboratories financial results Q3 2026 analyst conference call pet healthcare
Last updated: Oct 1, 2026

Biotech snapshot

Cash runway
$197M liquidity · $0M/mo burn
Low dilution risk